Based on the IRadimed Corporation stock forecast from 0 analysts, the average analyst target price for IRadimed Corporation is not available over the next 12 months. IRadimed Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of IRadimed Corporation is Slightly Bullish , which is based on 9 positive signals and 4 negative signals. At the last closing, IRadimed Corporation’s stock price was EUR 51.50. IRadimed Corporation’s stock price has changed by +4.67% over the past week, +5.97% over the past month and +25.00% over the last year.
No recent analyst target price found for IRadimed Corporation
No recent average analyst rating found for IRadimed Corporation
Company Overview IRadimed Corporation
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. Read Less
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infu...Read More
Frequently Asked Questions About IRadimed Corporation (46K:F) Stock
Stock Target Advisor's fundamental analysis for IRadimed Corporation's stock is Slightly Bullish .
46K:F stock's dividend yield is 1.10%.
Our analysis grades 46K:F stock's dividend yield at F. This means that 46K:F stock's dividend yield is above 30% of the stocks in the Medical Devices sector in the F exchange.
Based on this 46K:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 46K:F's stock to indicate what its average analyst target is.
46K:F stock's Price/Earning ratio is 35.68.
Our analysis grades 46K:F stock's Price / Earning ratio at F. This means that 46K:F stock's Price/Earning ratio is above 47% of the stocks in the Medical Devices sector in the F exchange.
Based on this 46K:F may be fairly valued for its sector
The last closing price of 46K:F's stock was EUR 51.50.
The most recent market capitalization for 46K:F is EUR 0.63B.
Unfortunately we do not have enough analyst data on 46K:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains IRadimed Corporation's stock.
As per our most recent records IRadimed Corporation has 148 Employees.
IRadimed Corporation's registered address is 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708.
You can get more information about it from IRadimed Corporation's website at https://www.iradimed.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About IRadimed Corporation (46K:F) Stock
Stock Target Advisor's fundamental analysis for IRadimed Corporation's stock is Slightly Bullish .
46K:F stock's dividend yield is 1.10%.
Our analysis grades 46K:F stock's dividend yield at F. This means that 46K:F stock's dividend yield is above 30% of the stocks in the Medical Devices sector in the F exchange.
Based on this 46K:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 46K:F's stock to indicate what its average analyst target is.
46K:F stock's Price/Earning ratio is 35.68.
Our analysis grades 46K:F stock's Price / Earning ratio at F. This means that 46K:F stock's Price/Earning ratio is above 47% of the stocks in the Medical Devices sector in the F exchange.
Based on this 46K:F may be fairly valued for its sector
The last closing price of 46K:F's stock was EUR 51.50.
The most recent market capitalization for 46K:F is EUR 0.63B.
Unfortunately we do not have enough analyst data on 46K:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains IRadimed Corporation's stock.
As per our most recent records IRadimed Corporation has 148 Employees.
IRadimed Corporation's registered address is 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708.
You can get more information about it from IRadimed Corporation's website at https://www.iradimed.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 46K:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
